Top Markets
Coin of the day
MOLOGEN Lifescience AG MOLOGEN Lifescience AG

MOLOGEN Lifescience AG

U1DA
Rank in Stocks #40050
Finchain Capital Partners AG functions as an investment firm, concentrating its... Finchain Capital Partners AG functions as an investment firm, concentrating its capital deployment on early-stage companies, specifically during their seed, Series A, and Series B funding rounds. The company was established on February 27, 2015, and is based in Dusseldorf, Germany.
Share Price
$3.32
Last synced: 2026-08-13
Market Cap
$261.55K
Change (1 day)
0.00%
Change (1 year)
42.54%
Country
DE
Trade MOLOGEN Lifescience AG (U1DA)
Operating Margin for MOLOGEN Lifescience AG (U1DA)
Operating Margin as of 2026 TTM: 0.00%
According to MOLOGEN Lifescience AG latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for MOLOGEN Lifescience AG from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
31.12% -
US
52.08% -
US
0.00% -
SE
17.65% -
US
63.13% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.